Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022662666> ?p ?o ?g. }
- W2022662666 endingPage "541" @default.
- W2022662666 startingPage "535" @default.
- W2022662666 abstract "School-based influenza immunization can effectively address accessibility barriers, but injected inactivated influenza vaccines (IIV) may not be acceptable to some children and parents in school settings.To better understand the feasibility of offering intranasal live attenuated influenza vaccines (LAIV) through schools, we assessed uptake, stakeholder acceptability, and cost of school-based delivery of LAIV compared to IIV.We piloted an open-label cluster randomized trial involving 10 elementary schools in Peterborough, Ontario during the 2013-2014 influenza vaccination campaign. Schools were randomized to having students receive IIV or LAIV at publicly-funded school-based clinics organized by the local public health department. We measured the percentage of students vaccinated with at least one dose of influenza vaccine at school. Stakeholder acceptability was evaluated through a questionnaire of parents and interviews of public health department personnel and school principals. We compared the costs per dose of vaccine administered, including staff time and costs of vaccines and supplies.Single-dose influenza vaccine uptake was higher for the five schools offering LAIV than for the five offering IIV (19.3% vs. 12.2%, p=0.02). Interviews with nine school principals and five public health department personnel suggested that the clinics ran smoothly with little disruption to school routines, and that LAIV was associated with increased efficiency and calmer children. All interviewees cited unfamiliarity with LAIV and the study recruitment package length as potential reasons for low uptake. The cost per vaccine dose administered was $38.67 for IIV and $43.50 for LAIV.Use of LAIV in school-based clinics was associated with increased vaccine uptake and the perception among immunizing staff of reduced child anxiety, but also slightly higher vaccine administration costs, compared to IIV. However, uptake was low for both groups. More effective strategies to promote influenza vaccines and to obtain parent consent may improve vaccine uptake.ClinicalTrials.gov NCT01995851.Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network." @default.
- W2022662666 created "2016-06-24" @default.
- W2022662666 creator A5004029519 @default.
- W2022662666 creator A5007833843 @default.
- W2022662666 creator A5015707477 @default.
- W2022662666 creator A5026999091 @default.
- W2022662666 creator A5048758518 @default.
- W2022662666 creator A5052617007 @default.
- W2022662666 creator A5055982941 @default.
- W2022662666 creator A5063694419 @default.
- W2022662666 creator A5067527009 @default.
- W2022662666 creator A5070260188 @default.
- W2022662666 creator A5072544703 @default.
- W2022662666 creator A5078064190 @default.
- W2022662666 creator A5080558644 @default.
- W2022662666 creator A5084198418 @default.
- W2022662666 creator A5091714684 @default.
- W2022662666 date "2015-01-01" @default.
- W2022662666 modified "2023-10-06" @default.
- W2022662666 title "Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: A cluster randomized trial" @default.
- W2022662666 cites W1973529506 @default.
- W2022662666 cites W1975489102 @default.
- W2022662666 cites W1979631310 @default.
- W2022662666 cites W1979689975 @default.
- W2022662666 cites W1997219088 @default.
- W2022662666 cites W1999866305 @default.
- W2022662666 cites W2001864099 @default.
- W2022662666 cites W2003718127 @default.
- W2022662666 cites W2021468484 @default.
- W2022662666 cites W2022048722 @default.
- W2022662666 cites W2026646453 @default.
- W2022662666 cites W2034372360 @default.
- W2022662666 cites W2062170580 @default.
- W2022662666 cites W2070750060 @default.
- W2022662666 cites W2072436942 @default.
- W2022662666 cites W2073671231 @default.
- W2022662666 cites W2074295539 @default.
- W2022662666 cites W2077292419 @default.
- W2022662666 cites W2083450984 @default.
- W2022662666 cites W2084133800 @default.
- W2022662666 cites W2145603505 @default.
- W2022662666 cites W2168903302 @default.
- W2022662666 cites W4238434004 @default.
- W2022662666 cites W4250014650 @default.
- W2022662666 doi "https://doi.org/10.1016/j.vaccine.2014.11.044" @default.
- W2022662666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25488331" @default.
- W2022662666 hasPublicationYear "2015" @default.
- W2022662666 type Work @default.
- W2022662666 sameAs 2022662666 @default.
- W2022662666 citedByCount "12" @default.
- W2022662666 countsByYear W20226626662015 @default.
- W2022662666 countsByYear W20226626662016 @default.
- W2022662666 countsByYear W20226626662019 @default.
- W2022662666 countsByYear W20226626662020 @default.
- W2022662666 countsByYear W20226626662021 @default.
- W2022662666 crossrefType "journal-article" @default.
- W2022662666 hasAuthorship W2022662666A5004029519 @default.
- W2022662666 hasAuthorship W2022662666A5007833843 @default.
- W2022662666 hasAuthorship W2022662666A5015707477 @default.
- W2022662666 hasAuthorship W2022662666A5026999091 @default.
- W2022662666 hasAuthorship W2022662666A5048758518 @default.
- W2022662666 hasAuthorship W2022662666A5052617007 @default.
- W2022662666 hasAuthorship W2022662666A5055982941 @default.
- W2022662666 hasAuthorship W2022662666A5063694419 @default.
- W2022662666 hasAuthorship W2022662666A5067527009 @default.
- W2022662666 hasAuthorship W2022662666A5070260188 @default.
- W2022662666 hasAuthorship W2022662666A5072544703 @default.
- W2022662666 hasAuthorship W2022662666A5078064190 @default.
- W2022662666 hasAuthorship W2022662666A5080558644 @default.
- W2022662666 hasAuthorship W2022662666A5084198418 @default.
- W2022662666 hasAuthorship W2022662666A5091714684 @default.
- W2022662666 hasBestOaLocation W20226626661 @default.
- W2022662666 hasConcept C126322002 @default.
- W2022662666 hasConcept C133239900 @default.
- W2022662666 hasConcept C138816342 @default.
- W2022662666 hasConcept C147483822 @default.
- W2022662666 hasConcept C159110408 @default.
- W2022662666 hasConcept C168563851 @default.
- W2022662666 hasConcept C187212893 @default.
- W2022662666 hasConcept C203014093 @default.
- W2022662666 hasConcept C22070199 @default.
- W2022662666 hasConcept C2780689484 @default.
- W2022662666 hasConcept C2780801004 @default.
- W2022662666 hasConcept C512399662 @default.
- W2022662666 hasConcept C71924100 @default.
- W2022662666 hasConceptScore W2022662666C126322002 @default.
- W2022662666 hasConceptScore W2022662666C133239900 @default.
- W2022662666 hasConceptScore W2022662666C138816342 @default.
- W2022662666 hasConceptScore W2022662666C147483822 @default.
- W2022662666 hasConceptScore W2022662666C159110408 @default.
- W2022662666 hasConceptScore W2022662666C168563851 @default.
- W2022662666 hasConceptScore W2022662666C187212893 @default.
- W2022662666 hasConceptScore W2022662666C203014093 @default.
- W2022662666 hasConceptScore W2022662666C22070199 @default.
- W2022662666 hasConceptScore W2022662666C2780689484 @default.
- W2022662666 hasConceptScore W2022662666C2780801004 @default.
- W2022662666 hasConceptScore W2022662666C512399662 @default.
- W2022662666 hasConceptScore W2022662666C71924100 @default.